Resource overview
When your product shelf life is measured in days, a 14-day sterility test is more than inconvenient – it’s a release bottleneck.
Cell and gene therapies, ATMPs, and advanced biologics demand faster sterility assurance without compromising GMP compliance or patient safety. Traditional culture-based methods simply weren’t built for today’s accelerated manufacturing timelines.
This session, led by industry experts, explores how digital PCR is enabling rapid, highly sensitive sterility testing, supporting faster batch release, stronger contamination control, and greater operational confidence.
Rapid sterility testing is no longer optional for advanced therapies – it’s becoming operationally essential.
Resource Details
- Document type: Webinar
- Watch time: 1 hour
Key takeaways
- Discover rapid sterility testing methods that address the challenge of lengthy testing times, improving efficiency and ensuring timely product release
- Gain insights into how digital PCR technology enhances testing accuracy and sensitivity, detecting contaminants quickly and reliably
- Understand the evolving landscape of sterility testing in the pharmaceutical industry, identifying both challenges and opportunities for growth
- Learn from real-world case studies on rapid testing implementations in the field of cell and gene therapy
- Explore strategies to maintain product safety and quality while meeting tight delivery schedules, enhancing overall operational effectiveness.
The session discusses future trends in sterility testing and showcase successful rapid sterility testing in cell and gene therapy products, demonstrating practical applications and benefits.
